Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02771405
PHASE3
Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC
Sponsor: National Hepatology & Tropical Medicine Research Institute
View on ClinicalTrials.gov
Summary
The study will recruit 150 patients with HCV related HCC ,after HCC treatment the patients will undergo treatment with different regimens of DAAs.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2016-03
Completion Date
2018-01
Last Updated
2026-04-13
Healthy Volunteers
No
Interventions
DRUG
Sofosbuvir
Sofosbuvir 400 mg orally once daily
DRUG
Ribavirin
Ribavirin (RBV) 200 mg tablets administered orally in a divided daily dose (\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)
DRUG
Simeprevir
Simeprevir 150 mg orally once daily
DRUG
daclatasvir
Daclatasvir 60 mg orally once daily
DRUG
Ledipasvir
Ledipasvir 90 mg orally once daily
Locations (1)
Amr Maged
Cairo, Egypt